Facial Injectables Global Strategic Analysis Report 2024: Market to Grow by Over $10 Billion During 2023-2030 [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Anika Therapeutics Inc. (ANIK)
Last anika therapeutics inc. earnings: 2/20 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.anikatherapeutics.com/investor-relations
Company Research
Source: Yahoo! Finance
The global market for Facial Injectables is estimated at US$18.1 Billion in 2023 and is projected to reach US$28.8 Billion by 2030, growing at a CAGR of 6.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. Key Insights: Market Growth: Understand the significant growth trajectory of the Botulinum Toxin Type A segment, which is expected to reach US$16 Billion by 2030 with a CAGR of a 6.7%. The Hyaluronic Acid (HA) segment is also set to grow at 7.6% CAGR over the next 7 years. Regional Analysis: Gain insights into the U.S. market, estimated at $4.8 Billion in 2023, and China, forecasted to grow at an impressive 11.3% CAGR to reach $7.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Why You Should Buy This Report: Detailed Market Analysis: Access a thorough analysis of the Global Facial Injecta
Show less
Read more
Impact Snapshot
Event Time:
ANIK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIK alerts
High impacting Anika Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
ANIK
News
- Global Viscosupplementation Market Size To Worth USD 9.15 Billion By 2033 | CAGR Of 8.10% [Yahoo! Finance]Yahoo! Finance
- HealthpointCapital and The Orthopaedic Summit: Evolving Techniques Course (OSET) Announce Inaugural Investor Day at Fontainebleau Las Vegas [Yahoo! Finance]Yahoo! Finance
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "equal weight" rating re-affirmed by analysts at Stephens. They now have a $24.00 price target on the stock.MarketBeat
- Anika Enters into Cooperation Agreement with Caligan Partners [Yahoo! Finance]Yahoo! Finance
ANIK
Earnings
- 5/8/24 - Miss
ANIK
Sec Filings
- 6/25/24 - Form DEFA14A
- 6/11/24 - Form ARS
- 6/11/24 - Form DEF
- ANIK's page on the SEC website